SZSai-Zhen Zeng

Sai-Zhen Zeng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sai-Zhen Zeng has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Aijun Chen

    National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China

    1 shared publication
  • Chao Wang

    National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases National Institute for Viral Disease Control and Prevention, China CDC Beijing China

    1 shared publication
  • Jingdong Song

    National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100052, China

    1 shared publication
  • Le Yang

    Department of Children's Medical Center, Hunan Provincial People's Hospital and the First Affiliated Hospital of Hunan Normal University, Changsha, China

    1 shared publication
  • Le-Yun Xie

    Department of Children's Medical Center, Hunan Provincial People's Hospital and the First Affiliated Hospital of Hunan Normal University, Changsha, China

    1 shared publication
  • Li Peng

    Department of Children's Medical Center, Hunan Provincial People's Hospital and the First Affiliated Hospital of Hunan Normal University, Changsha, China

    1 shared publication

Latest Publications

  • Cytopathic Effect and Morphogenesis of WUPyV in Human Airway Epithelial Cells

    by Yiman Huang, Chao Wang, Aijun Chen, Saizhen Zeng, Xiaocao Meng, Shiyuan Fan, Jingdong Song, Lishu Zheng

    Washington University polyomavirus (WUPyV), a member of the polyomavirus family capable of infecting the human respiratory tract, exhibits high prevalence in human populations. However, confirmation of its pathogenicity and aetiology has been hindered by challenging culture conditions. To investigate the infective endocytosis of WUPyV, a novel infection model was developed using human airway organoids (HAOs); viral replication dynamics, cell tropism, endocytosis mechanisms, and morphogenesis in human airway epithelium (HAE) were characterized. The results indicated that WUPyV replicates efficiently and infects multiple cell types within the respiratory epithelium. After JC polyomavirus, WUPyV is the second human polyomavirus known to enter cells via clathrin‐mediated endocytosis, independent of caveolar/lipid raft‐mediated endocytosis or macropinocytosis. Consistent with other polyomaviruses, WUPyV is transported to the nucleus for replication and assembly through a lipid‐dependent pathway requiring tyrosine kinase activity and endosome/lysosome acidification. Assembled viral particles were observed in nuclear pores; they were ultimately released extracellularly through vesicles and schistocytes. High‐titre WUPyV infection caused extensive structural damage to the HAE and its cilia. Our findings provide important insights into the endocytosis, morphogenesis, and ultrastructural damage induced by WUPyV, supporting the notion that WUPyV is an underestimated human pathogen.

  • Open Access

    Seasonal epidemiological and clinical characteristics of pediatric patients with respiratory syncytial virus infection by age during COVID-19: a cross-sectional study

    by Le-Yun Xie, Ying-Gang Peng, Tao Wang, Tian Yu, Xian Hu, Le Yang, Li-Li Zhong, Li Peng, Sai-Zhen Zeng

    Background: To date, reports have been conflicting regarding changes in the age distribution and severity of respiratory syncytial virus (RSV) hospitalizations in children since the beginning of the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to investigate the epidemiological trends and clinical characteristics of RSV infection among children hospitalized with acute lower respiratory tract infection (ALRTI) before and during the COVID-19 pandemic. Methods: A cross-sectional study was conducted from January 2018 to December 2022 in Hunan, China. Data were collected on hospitalized children 14 years or younger with RSV-positive ALRTIs admitted to the Children’s Medical Center of Hunan Provincial People’s Hospital and the First Affiliated Hospital of Hunan Normal University. We evaluated their demographic characteristics, clinical features, and disease severity before and during the COVID-19 pandemic. Results: RSV was detected in 4,255 (17.68%) of the 24,072 children, and the highest detection was 30.90% (1,248 of 4,039) in 2021. The RSV detection rates differed significantly among the years (χ2=664.741, PZ=−12.688, Pvs. 23.61% during the epidemic), and the proportion of children in the 24–59 months old group increased (12.17% before vs. 24.29% during the epidemic) (χ2=92.225, Pvs. 0.89%, χ2=4.178, P=0.04). However, there were no differences in hospitalization duration and the proportion of children admitted to the pediatric intensive care unit (PICU) before and during the COVID-19 epidemic. Conclusions: During the COVID-19 pandemic, RSV-infected children were older and had a lower rate of wheezing and disease severity increased in the age group of under 2 years old.